NCT01784757View on ClinicalTrials.gov

Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

December 31, 2020

Conditions

Prostate Cancer

Interventions

DRUG

ODM-201 Tablet A

Tablet A formulation of ODM-201

DRUG

ODM-201 Tablet B

Tablet B formulation of ODM-201

DRUG

ODM-201 capsule formulation

Capsule formulation of ODM-201

Trial Locations (1)

Unknown

P. Stradina Clinical University Hospital, Riga

Sponsors

Collaborators (1)

Endo Pharmaceuticals

All Listed Sponsors

collaborator

Endo Pharmaceuticals

INDUSTRY

lead

Orion Corporation, Orion Pharma

INDUSTRY